Amplia Therapeutics Limited (ASX:ATX)
Australia · Delayed Price · Currency is AUD 0.1250
+0.0025 (2.04%)
Dec 9, 2025, 3:04 PM AEST
Amplia Therapeutics Market Cap
Amplia Therapeutics has a market cap or net worth of 62.85 million as of December 8, 2025. Its market cap has increased by 103.88% in one year.
Market Cap
62.85M
Enterprise Value
34.08M
Revenue
5.01M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.13
Market Cap Chart
Since December 23, 2013, Amplia Therapeutics's market cap has increased from 34.50M to 62.85M, an increase of 82.20%. That is a compound annual growth rate of 5.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 8, 2025 | 62.85M | 82.03% |
| Dec 31, 2024 | 34.53M | 122.47% |
| Dec 28, 2023 | 15.52M | - |
| Dec 29, 2022 | 15.52M | -51.48% |
| Dec 31, 2021 | 31.99M | 24.04% |
| Dec 31, 2020 | 25.79M | 623.82% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 89.55B |
| Pro Medicus | 25.77B |
| Cochlear | 17.73B |
| Sonic Healthcare | 11.39B |
| Ramsay Health Care | 8.21B |
| Ansell | 5.15B |
| Telix Pharmaceuticals | 4.94B |
| Mesoblast | 3.50B |